CliffBio
small molecule

BUSPAR

BUSPIRONE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyBRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE

Drug detail

Brand nameBUSPAR
Active ingredientBUSPIRONE HYDROCHLORIDE
Strength15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalDecember 2000
Marketing statusDISCN

More from BRISTOL MYERS SQUIBB CO PHARMACEUTICAL RESEARCH INSTITUTE

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

BUSPAR patent cliff — loss of exclusivity — | CliffBio